// App-Quantinova.ai

299 : Patient-derived tumor microenvironment models uncover non-autonomous TKI resistance mechanisms in NSCLC

Researchers

Presenter

  • Haichuan Hu

Principal Investigators

  • Matthew Niederst

  • Jeffrey Engelman

Medical Centers

  • MGH Cancer Center, Charlestown, MA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • Epidermal growth factor receptor

  • Growth differentiation factor 15

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A